Previously, for those with diabetes, hypertension and a low risk of atherosclerotic CV disease (10-year risk less than 15%), a blood pressure target of less than 140/90 mmHg was the recommendation
36%, P = 0.04), improvement in fibrosis stage did not differ significantly between groups (26% with liraglutide vs
The product has achieved remarkable success, with over 80% of prescriptions coming from new patients who had never used GLP-1 medications before
"Will I regain weight after stopping medication?" Evidence suggests weight often returns after stopping GLP-1 treatment, which is why clinician-led maintenance planning and lifestyle support are important
Nuwayhid encourages anyone interested in learning whether they qualify to schedule a consultation with CMC Weight Loss, where the care team can determine the most appropriate treatment plan for their individual needs